A biopsy of the lung mass confirmed invasive, moderately differentiated adenocarcinoma, with immunohistochemical markers (TTF1 + ) and an epidermal growth factor receptor (EGFR) mutation (L858R), indicating a bronchopulmonary origin. Here, EGFR is linked to adenocarcinoma.